Skip to Main Content

Author Details

Temitope Folaranmi
Merck & Co., Inc.
2014
15
8
PMIDPaper TitleJournal TitlePublished Year
32614654Response to Shami et al. 'Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong Kong' (Hum Vacc Immunother 2020).Hum Vaccin Immunother2021
33567914Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature.Expert Rev Vaccines2021
34019468Sequential administration of Prevnar 13â¿¢ and PNEUMOVAXâ¿¢ 23 in healthy participants 50 years of age and older.Hum Vaccin Immunother2021
33358263The Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial: Further reflections on the design and results.Vaccine2021
33478306Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence.Expert Rev Vaccines2021
31799889A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) coverage among patients with chronic medical condition aged 50 and older.Hum Vaccin Immunother2020
32045317A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) revaccination coverage rate among elderly adults aged 65 and older and physician's attitude.Hum Vaccin Immunother2020
28505234Increased Risk for Meningococcal Disease Among Men Who Have Sex With Men in the United States, 2012-2015.Clin Infect Dis2017
31384251Systematic review and meta-analysis of pertussis epidemiology in Latin America and the Caribbean: 1980-2015.Rev Panam Salud Publica2017
27811226Zika virus in Africa: revitalising the discourse of health systems.Perspect Public Health2016
25767300Big data in global health: improving health in low- and middle-income countries.Bull World Health Organ2015
26492381Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015.MMWR Morb Mortal Wkly Rep2015
26275321Nigeria's new government and public financing for universal health coverage.Lancet Glob Health2015
26068564Use of Serogroup B Meningococcal Vaccines in Persons Aged â¿¥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015.MMWR Morb Mortal Wkly Rep2015
24395839mHealth in Africa: challenges and opportunities.Perspect Public Health2014
  • 1 - 15 of 15

Recommended Authors

Hospital Clinico Universitario de Santiago de Compostela
Career Start Year 2014
Number of shared co-authors 0
US Centers for Disease Control and Prevention
Career Start Year 2014
Number of shared co-authors 0
US Centers for Disease Control and Prevention
Career Start Year 2013
Number of shared co-authors 0
Dalla Lana School of Public Health, University of Toronto
Career Start Year 2012
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 2011
Number of shared co-authors 0
University College London Hospitals National Health Service Foundation Trust
Career Start Year 2010
Number of shared co-authors 0
School of Public Health, Universite de Montreal
Career Start Year 2010
Number of shared co-authors 0
University of Washington
Career Start Year 2008
Number of shared co-authors 0
Yale School of Public Health, Yale University
Career Start Year 2008
Number of shared co-authors 0
Boston University
Career Start Year 2007
Number of shared co-authors 0
Stanford University
Career Start Year 2006
Number of shared co-authors 0
College of Public Health, University of Nebraska Medical Center
Career Start Year 2006
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 2005
Number of shared co-authors 0
Yale School of Public Health
Career Start Year 2004
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 2004
Number of shared co-authors 0
Geneva Center for Emerging Viral Diseases, Geneva University Hospitals
Career Start Year 2003
Number of shared co-authors 0
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 0
U.S. Centers for Disease Control and Prevention
Career Start Year 2002
Number of shared co-authors 0
Career Start Year 2001
Number of shared co-authors 0
Hospital Clinico Universitario de Santiago de Compostela
Career Start Year 1998
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 1998
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 1995
Number of shared co-authors 0
UCSF School of Medicine, University of California Health
Career Start Year 1993
Number of shared co-authors 0
Oak Crest Institute of Science
Career Start Year 1992
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 1991
Number of shared co-authors 0
University of Washington, Fred Hutchinson Cancer Center
Career Start Year 1989
Number of shared co-authors 0
University of Pittsburgh
Career Start Year 1989
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1980
Number of shared co-authors 0
University of California berkeley
Career Start Year 1971
Number of shared co-authors 0

Collaborators

The University of Auckland
Co-authored papers 1
St. Michael's Hospital
Co-authored papers 1
The George Institute for Global Health
Co-authored papers 1
Burnet Institute
Co-authored papers 1
Harvard T.H. Chan School of Public Health, MIT
Co-authored papers 1